Martin Däumer is the responsible lab manager for molecular infectious diseases at the Institute of Immunology and Genetics, Kaiserslautern, Germany. He received his diploma in biology from the faculty of science at the University of Bonn, Germany. Specialized in medical virology he worked as a research assistant at the Institute of Medical Microbiology and Immunology, University of Bonn, Germany, accompanied by research fellowships at the University of South Alabama, Mobile, and the University of California San Francisco, USA.
From 2000 to 2007 Martin Däumer joined Dr. Rolf Kaiser’s group at the Institute of Virology, University of Cologne. He was significantly involved in the Arevir project, focusing on the calculation and establishment of clinically relevant cutoffs within the geno2pheno® drug resistance interpretation system. Furthermore, he is a member of the German HIV-GRADE board (www.hiv-grade.de).
At the Institute of Immunology and Genetics,he now focuses on the analysis of viral dynamics and drug resistance/tropism testing by applying Next-Generation-Sequencing technologies.